SCM
NVAX icon

Sio Capital Management’s Novavax NVAX Stock Holding History

Sio Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-340,000
Closed -$3.5M – 50
2022
Q4 		$3.5M Buy
+340,000
New +$6M 1.29% 16
2021
Q2 		– Sell
-25,700
Closed -$4.66M – 93
2021
Q1 		$4.66M Buy
+25,700
New +$5.12M 0.95% 35

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sio Capital Management's NVAX Position: Q1 2023 in Review

Sio Capital Management sold out of Novavax (NVAX) in Q1 2023, closing a stake of 340,000 shares — an estimated $3.5M sold.

Sio Capital Management first reported a position in NVAX in Q1 2021 and held it in 2 quarters. The position peaked at $4.66M in Q1 2021. 222 funds tracked by Wall St. Rank hold NVAX as of Q1 2023.

  • Sio Capital Management reported no remaining Novavax position as of Q1 2023 after selling out during the quarter.
  • Sio Capital Management sold 340,000 Novavax shares in Q1 2023, an estimated $3.5M.
  • Sio Capital Management first reported a position in Novavax in Q1 2021 and held it in 2 quarters.
  • Sio Capital Management's Novavax position peaked at $4.66M in Q1 2021.
  • 222 funds tracked by Wall St. Rank held Novavax as of Q1 2023.

Based on Sio Capital Management's 13F filing for Q1 2023, filed 12 May 2023.